Despite reporting positive operating cash flow, the company faces liquidity pressure from working capital volatility, including a $4.0 million cash outflow in 2026Q1, and inconsistent free cash flow margins that dropped to 5.6% in 2025Q3.
| Metric | TTM | Sep'25 | Sep'24 | Sep'23 | Sep'22 | Sep'21 | Sep'20 | Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 |
|---|
| Cash from Operations | 37.47M | 37.69M | 35.38M | 36.98M | 26.34M | 17.76M | 9.89M | 8.39M | 10.64M | -6.07M | -4.46M | -2.38M | -1.17M | 214.32K | -1.12M | -1.5M | -1.13M | -302.23K | -94.06K | 987.89K | 158.53K | -468.41K | -66.03K | -11.3K | 78.92K | -38.07K | -171.14K | 28.07K |
| Operating CF Margin % | - | 15.36% | 14.39% | 17.47% | 18.84% | 17.35% | 13.52% | 13.72% | 19.5% | -9.86% | -4.63% | -4.46% | -6.16% | 5.56% | -28.32% | -108.08% | -2986.55% | -19.31% | -4.25% | 16.76% | 2.83% | -10.18% | -1.1% | -0.27% | 2.45% | -1.96% | -43.81% | - |
| Operating CF Growth % | 95.29% | 6.53% | -4.32% | 40.37% | 48.33% | 79.52% | 17.92% | -21.18% | 275.42% | -36.03% | -87.35% | -103.43% | -646.1% | 119.1% | 25.36% | -32.47% | -275.51% | -221.3% | -109.52% | 523.16% | 133.84% | -609.44% | -484.29% | -114.32% | 307.3% | 77.76% | -709.65% | - |
| Net Income | -10.74M | -10.7M | -6.76M | -3.78M | 6.68M | -6.17M | -3.79M | -5.58M | -5.39M | -19.15M | -57.37M | -18.32M | -1.4M | -2.47M | -548K | -1.53M | -1.59M | -3.93K | -1.55M | 156.59K | -208.27K | -710.13K | -1.25M | -41.54K | -156.37K | -336.47K | -241.26K | -34.05K |
| Depreciation & Amortization | 52.13M | 51.92M | 50.55M | 41.23M | 23.04M | 17.73M | 10.98M | 10.55M | 12.02M | 12.45M | 22.18M | 8.67M | 2.21M | 386.02K | 297.84K | 116.82K | 7.42K | 33.73K | 47.51K | 236.5K | 217.27K | 177.09K | 186.96K | 166.92K | 135.54K | 130.89K | 77.87K | 263 |
| Stock-Based Compensation | 4.81M | 4.04M | 2.48M | 5.28M | 7.59M | 4.95M | 128.44K | 1.56M | 1.29M | -1.21M | 7.92M | 6.83M | 1.32M | 63.21K | 70.55K | 136.33K | 212.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 83K | 85K | 342K | -548K | 0 | -3.8M | 4.96M | 4.3M | 4.06M | 0 | -8.15M | 621.15K | -1.08M | 2.8M | 0 | 16.68K | -97.1K | 0 | 56.1K | -123.25K | 0 | 86.28K | 18K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -4.76M | -6.56M | -3.54M | -3.19M | -11.72M | 13.9M | 1.12M | 1.39M | 3.04M | 6.04M | 55.19M | 14.02M | 2.1M | 94.4K | 95.91K | -36.47K | 25.44K | -464.99K | 1.02M | 420.98K | -20.18K | 112.8K | 827.3K | -47.06K | 8.24K | 5.95K | 5.31K | 1.71K |
| Working Capital Changes | -4.13M | -1.08M | -7.7M | -2.01M | 758K | -8.85M | -3.5M | -3.82M | -4.38M | -4.2M | -24.24M | -14.19M | -4.32M | -658.65K | -1.04M | -204.34K | 311.73K | 132.96K | 329.74K | 297.08K | 169.7K | -134.45K | 156.38K | -89.62K | 91.5K | 161.56K | -13.06K | 60.15K |
| Change in Receivables | 991.21K | 2.58M | -3.29M | -3.06M | -201K | -8.82M | -3.86M | -5.16M | -7M | -4.21M | -19.74M | -7.38M | -4.09M | -428.24K | -455.73K | -386.57K | -33.59K | -28.83K | -19.92K | 83.01K | -34.43K | 0 | -155K | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -4.45M | -2.42M | -3.42M | -60K | -2.42M | -44K | -1.33M | 637.56K | 3.69M | -3.98M | 176.46K | -1.64M | -272.97K | -266.05K | 57.26K | -66.59K | -13.69K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.66K | 0 | 0 | 0 |
| Change in Payables | -1.63M | -3.41M | 3.13M | 3.12M | 3.35M | 518K | 1.66M | 0 | -4.12M | 0 | -3.75M | -4.7M | -539.91K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -31.27M | -32.95M | -10.31M | -82.83M | -42.49M | -17.84M | -5.93M | 1.77M | -723.68K | 9.3M | -22.93M | -35.45M | -3.08M | -395.14K | -663.73K | -661.64K | -161.01K | 563.62K | -41.28K | -313.24K | -6.57K | -21.32K | -896.84K | -100.83K | -348.36K | -11.55K | -105.57K | -68.08K |
| Capital Expenditures | -10.75M | -12.35M | -10.31M | -6.85M | -9.16M | -5.05M | -69.02K | -1.36M | -530.18K | -2.44M | -2.94M | -5.58M | -1.2M | -91.36K | -738.54K | -661.64K | -129.52K | -1.22K | -1.48K | -120.03K | -6.57K | -21.32K | -200.83K | -83.91K | -111.78K | -8.58K | -154.69K | 0 |
| CapEx % of Revenue | 3.75% | 5.04% | 4.19% | 3.24% | 6.55% | 4.93% | 0.09% | 2.23% | 0.97% | 3.97% | 3.05% | 10.45% | 6.34% | 2.37% | 18.64% | 47.57% | 340.83% | 0.08% | 0.07% | 2.04% | 0.12% | 0.46% | 3.36% | 1.99% | 3.47% | 0.44% | 39.6% | - |
| Acquisitions | 0 | -21.82M | -210K | -76.04M | -33.52M | -12.89M | -6.05M | 2.97M | -422.6K | -129.78K | -19.99M | -29.87M | -1.88M | -303.79K | 0 | 0 | 0 | 0 | 0 | -193.21K | 0 | 0 | -680.88K | 0 | -18.52K | -38.1K | -33.76K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -20.53M | 1.23M | 210K | 65K | 193K | 98K | 190.79K | 161.66K | 229.1K | 11.87M | 0 | 0 | 0 | 0 | 74.81K | 0 | -31.49K | 564.84K | -39.8K | 0 | 0 | 0 | -15.13K | -16.93K | -218.05K | 0 | 0 | -31.43K |
| Cash from Financing | -11.82M | -7.76M | -26.15M | 54.43M | -9.85M | 4.84M | 10.48M | -5.03M | -10.51M | -6.53M | -6.54M | 60.16M | 13.6M | 3.2M | 1.42M | 0 | 4.06M | -291.25K | -27.68K | -443.52K | -103.15K | -100.16K | 1.33M | 77.43K | 472.04K | 84.38K | 225.74K | 19.33K |
| Debt Issued (Net) | -11.85M | -7.58M | -25.5M | 27.22M | -5.07M | -12.96M | -6.96M | -8.92M | -10.89M | -1.79M | -3.15M | -740.41K | 5.73M | 3.2M | 720.05K | 0 | 0 | -435.08K | -8.26K | 329.69K | -47.58K | -143.77K | 628.51K | -56.44K | 3.42K | -58.9K | -9.92K | 0 |
| Equity Issued (Net) | 508.15K | -130.5K | 357.03K | 1000K | 523.47K | 1000K | 1000K | 1000K | 252K | 4K | 0 | 1000K | 1000K | 0 | 685.88K | 0 | 1000K | 227.21K | 235.8K | 0 | 113.81K | 114.3K | 702.26K | 155.84K | 366.83K | 143.28K | 235.66K | 19.33K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -130.52K | -130.5K | -214.22K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -476.95K | -49.35K | -1.01M | -653.79K | -5.3M | -1.21M | -1.75M | 756.65K | 123.7K | -4.75M | -3.38M | 14.84M | 2.44M | 0 | 11.52K | 0 | 57.89K | -83.38K | -255.22K | -773.2K | -169.38K | -70.69K | 0 | -21.98K | 101.79K | 0 | 0 | 0 |
| Net Change in Cash | -4.91M | -3.26M | -1.03M | 8.69M | -26.1M | 5.38M | 14.66M | 6.44M | 727.55K | -2.74M | -34.35M | 28.23M | 9.58M | 3.02M | -362.21K | -2.19M | 2.79M | -29.86K | -163.03K | 231.13K | 48.81K | -589.88K | 367.91K | -34.71K | 202.6K | 34.76K | -50.97K | -20.68K |
| Free Cash Flow | 26.69M | 25.34M | 25.07M | 30.13M | 17.18M | 13.65M | 9.82M | 7.03M | 10.11M | -7.33M | -7.4M | -7.96M | -2.37M | 122.97K | -1.86M | -2.17M | -1.26M | -303.45K | -95.54K | 867.86K | 151.96K | -489.72K | -266.85K | -95.21K | -32.87K | -46.65K | -325.83K | 28.07K |
| FCF Margin % | 9.31% | 10.33% | 10.19% | 14.23% | 12.29% | 13.33% | 13.43% | 11.49% | 18.53% | -11.91% | -7.68% | -14.9% | -12.51% | 3.19% | -46.95% | -155.64% | -3327.38% | -19.38% | -4.32% | 14.73% | 2.71% | -10.65% | -4.47% | -2.26% | -1.02% | -2.4% | -83.41% | - |
| FCF Growth % | 17.33% | 1.08% | -16.79% | 75.34% | 25.92% | 38.9% | 39.79% | -30.51% | 237.93% | 0.92% | 7.02% | -235.18% | -2031.26% | 106.61% | 14.06% | -71.23% | -316.68% | -217.6% | -111.01% | 471.12% | 131.03% | -83.52% | -180.28% | -189.7% | 29.55% | 85.68% | -1260.74% | - |
| FCF per Share | 0.61 | 0.59 | 0.59 | 0.76 | 0.46 | 0.45 | 0.43 | 0.34 | 0.50 | -0.39 | -0.42 | -0.69 | -0.37 | 0.04 | -0.58 | -0.72 | -0.59 | -5.55 | -1.53 | 13.67 | 2.16 | -6.12 | -4.03 | -8.19 | -4.16 | -9.16 | -82.05 | 11.18 |
| FCF Conversion (FCF/Net Income) | -2.49x | -3.52x | -5.23x | -13.28x | 5.44x | -2.88x | -2.16x | -1.50x | 0.73x | 0.32x | 0.08x | 0.13x | 0.83x | -0.08x | 2.05x | 0.95x | 0.71x | -0.24x | 0.05x | 1.38x | -0.54x | 0.66x | 0.11x | 0.27x | -0.51x | 0.11x | 0.71x | -0.82x |
| Interest Paid | 1.77M | 0 | 6.83M | 6.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 1.25M | 680K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Regulatory reimbursement and integration
According to the provided financial data, QIPT consistently reports negative net income while generating positive operating cash flow, with the OCF/NI ratio frequently exceeding -8.0, suggesting that non-cash charges like depreciation are masking the underlying lack of true economic profitability in the current business model.
The persistent gap between accounting losses and cash generation indicates that the company relies heavily on non-cash expenses to maintain a positive cash flow profile. Investors should monitor whether this divergence is sustainable or if the high depreciation levels reflect an aging asset base that will eventually require significant reinvestment.
As reported in quarterly filings, free cash flow margins have fluctuated significantly from a high of 18.2% in 2023Q4 to a low of 5.6% in 2025Q3, reflecting a lack of predictable cash generation despite the company's focus on recurring revenue streams in the respiratory segment.
The erratic nature of FCF suggests that the company's operational efficiency is highly sensitive to timing differences in collections and capital expenditures. This volatility complicates the valuation of the business, as it remains unclear whether the company can achieve a stable, self-funding growth trajectory.
Based on the reported figures, capital expenditures as a percentage of revenue have ranged from 1.9% to 6.6% over the last ten quarters, indicating that the company must continuously deploy capital to maintain its rental equipment fleet and support its last-mile logistics infrastructure.
The variability in CapEx suggests that the company may be deferring necessary equipment upgrades during periods of cash pressure. Analysts should investigate whether current spending levels are sufficient to replace the aging respiratory equipment fleet without compromising service quality or patient outcomes.
As evidenced by the quarterly cash flow statements, working capital changes have frequently been a net drain on cash, with a significant $4.0 million outflow in 2026Q1, highlighting the inherent difficulties in managing collections within the complex and fragmented U.S. healthcare reimbursement environment.
The recurring negative impact of working capital on cash flow suggests that the company struggles with the timing of insurance adjudications and accounts receivable management. This inefficiency effectively traps cash in the balance sheet, limiting the company's ability to fund operations internally.
Quick answers to the most common questions about buying QIPT stock.
Quipt Home Medical Corp. (QIPT) generated $37.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Quipt Home Medical Corp. (QIPT) generated $25.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Quipt Home Medical Corp. (QIPT) spent $12.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Quipt Home Medical Corp. (QIPT) spent $0.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.